US stocks may have seen immense volatility lately but they are heading into the final quarter of 2026 after a strong run, with the S&P 500 on track for a…
-
-
Gold fell below $4,000 an ounce on Friday, October 23, breaking the support level FinanceFeeds identified a day earlier, even as financial markets priced a nearly 93% probability that the…
-
Moderna stock is down because investors sold a Phase 3 melanoma result they had already paid for, after the number leaked two days early and turned out to be a…
-
Bloom Energy shares BE traded lower in trading on Friday despite the fuel-cell maker reporting third-quarter earnings and revenue well above Wall Street expectations, as investors weighed its aggressive spending…
-
Sandisk (SNDK) stock rose 1.54% to $1,280.30 by midday Friday, recovering part of Thursday’s 8.51% fall, six days before Sandisk reports its own quarter. The slide came on a session…
-
The Nasdaq 100 (USTEC) is being pulled in two directions. Higher energy prices, linked to the situation in the Middle East, are keeping US inflation high and raising expectations that…
-
Spotify Technology shares SPOT rose on Thursday after the music streaming company forecast fourth-quarter operating income above Wall Street expectations, supported by subscriber growth and investments in artificial intelligence-powered features.…
-
Key Facts INmune Bio (NASDAQ: INMB) has signed a Master Services Agreement with Uniphar Durbin Ireland Limited covering international access, distribution and commercialisation of Ebstrocel™. Ebstrocel™ is an investigational allogeneic…
-
Quantum computers already exist, but the race to make them reliably useful for demanding commercial applications has a more specific deadline: 2029, according to Quantinuum CEO Rajeeb Hazra. Speaking with…
-
The obvious reading is that Silence Therapeutics has already been taken out at $20. It has not. Nasdaq’s official close on Monday 19 October 2026 was $19.58, up $10.90, or…